Stock ARCH ARCH BIOPARTNERS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Arch Biopartners Inc. Toronto S.E.

Equities

ARCH

CA03938C1041

Market Closed - Toronto S.E.
Other stock markets
 15:40:05 2024-06-28 EDT 		5-day change 1st Jan Change
1.68 CAD -1.18% Intraday chart for Arch Biopartners Inc. +1.82% +13.51%
06-27 Arch Biopartners Up More Than 2% After Announcing GMP Manufacturing Of Cilastatin Drug Product MT
06-27 Arch Biopartners Inc. Announces GMP Manufacturing of Cilastatin Drug Product CI

Evolution of the average Target Price on Arch Biopartners Inc.

Price target over the last 5 years

History of analyst recommendation changes

6440317fb6a23e5584f4a9d4a9e6.24VC81L0JvPDOi1Z3RTkuLz_900Njx7P1ZVDPCFEOGQ.qrB6mjeyEbqqdEApjniP_dSKgiJj7F2FseYlWXcldxyK8BO8G6B2mqR5Sg~8ae6d18e42c3da4208c80fee6ed4f35d

Analyst Recommendations on Arch Biopartners Inc.

Arch Biopartners Initiated at Market Perform, $3.50 Target Price at Raymond James MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.22
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Arch Biopartners Inc.

Raymond James

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ACHFF Stock
  4. ARCH Stock
  5. Consensus Arch Biopartners Inc.